27 publications
Name | Date | Type | Actions |
---|---|---|---|
Programme de rachat - June 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
02/07/2020 | Monthly communication regarding buyback programs | |
Vetoquinol is moving forward with the acquisition of Profender® and Drontal® and related pipeline assets following communication from the European commission June 9th, 2020 (Lure, France) - The European Commission (EC) has approved, under the EU merger Regulation, the proposed acquisition of Bayer’s Animal Health Division by Elanco Animal Health. |
09/06/2020 | Public releases | |
Programme de rachat - May 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
04/06/2020 | Monthly communication regarding buyback programs | |
Programme de rachat - April 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/05/2020 | Monthly communication regarding buyback programs | |
Dominique Derveaux appointed Group Chief Operations Officer
Effective April 1, 2020, Vetoquinol’s Board of Directors has appointed Dominique Derveaux Group Chief Operations Officer. In this capacity, he will run the Business, Marketing & Medical, Industrial, and Information Systems departments. He will report to Vetoquinol CEO Matthieu Frechin. |
28/04/2020 | Public releases | |
Availability of the 2019 universal registration document Vetoquinol informs that it has filed its 2019 Universal Registration Document with the Autorité des Marchés Financiers (AMF) on April 23, 2020. |
23/04/2020 | Public releases | |
Q1 2020 sales €103.4 million (Up 13.7%) Vetoquinol Group sales for Q1 2020 amounted to €103.4 million, up 13.7% as reported and up 13.4% at constant exchange rates. |
16/04/2020 | Public releases | |
Programme de rachat - March 2020 Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres |
06/04/2020 | Monthly communication regarding buyback programs | |
Information hebdomadaire relative aux transactions réalisées sur ses propres titres (30 mars 2020) Conformément aux dispositions de l’article 241-4 du Règlement Général de l’Autorité des Marchés Financiers |
30/03/2020 | Monthly communication regarding buyback programs | |
2019 annual results: group sales €396.0M, up 6.1% at constant exchange rates. Net income group share: €28.6M (7.2% of sales) At its meeting on March 24, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the 2019 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon. |
26/03/2020 | Public releases |